8.6(top 1%)
Impact Factor
9.3(top 1%)
extended IF
252(top 1%)
H-Index
9.9K
authors
24.5K
papers
896.5K
citations
9.8K
citing journals
193.5K
citing authors

Most Cited Articles of British Journal of Pharmacology

TitleYearCitations
Animal research: reporting in vivo experiments: the ARRIVE guidelines20102.7K
Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean?20041.5K
Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo19901.5K
Stimulus-secretion coupling: the concept and clues from chromaffin and other cells19681.2K
The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin20081.1K
The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate19831.1K
The orphan receptor GPR55 is a novel cannabinoid receptor20071.1K
Principles of early drug discovery20111.1K
The role of inflammation in CNS injury and disease2006901
The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide1987898
Sixth gaddum memorial lecture, National Institute for Medical Research, Mill Hill, January 1977. Presynaptic receptors and their role in the regulation of transmitter release1977880
Therapeutic antibodies: successes, limitations and hopes for the future2009879
Endothelial dysfunction in diabetes2000815
Rapid method for the determination of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in small regions of rat brain1970813
Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects2011793
Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS)2011755
Microglial M1/M2 polarization and metabolic states2016751
Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide2001747
Binding, gating, affinity and efficacy: the interpretation of structure-activity relationships for agonists and of the effects of mutating receptors1998727
A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation1989712
Guide to Receptors and Channels (GRAC), 5th edition2011702
The use of animal models in diabetes research2012697
Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics2009684
L-NG-nitro arginine (L-NOARG), a novel, L-arginine-reversible inhibitor of endothelium-dependent vasodilatation in vitro1990662
Role of transmitter uptake mechanisms in synaptic neurotransmission1971657